Phase 4 Pulmonary Hypertension Trial, Recruiting (NCT04484675)

Phase 4 Pulmonary Hypertension Trial, Recruiting NCT04484675 Sponsor: Zagazig University Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT04484675 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are scheduled to have mitral valve (heart valve) surgery using a heart-lung bypass machine
Before your surgery, a special ultrasound test of your heart showed that the blood pressure in your lung arteries is significantly high (at or above a certain level measured during that test)

Who may not be able to join:

Your surgery is planned without using a heart-lung bypass machine
You are currently in an unstable condition before surgery, meaning you already need medications or a medical device to keep your blood pressure and circulation stable
You have severely reduced heart pumping function (your heart is pumping less than 30% of its normal capacity)
You have a heart condition that was present from birth (congenital heart disease)
You have a medical reason why a special ultrasound probe placed in the throat and esophagus (food pipe) cannot be used during surgery
Your surgery is an emergency or a repeat operation on the same area
You have serious kidney or liver disease
You have a blood clotting disorder or a history of blood clots being treated with blood-thinning medications

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Heba M EL-Asser, MD, Zagazig University

Phone: 01062393152

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04484675

Sponsor: Zagazig University

Phase: Phase 4

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: 01062393152

More information: https://clinicaltrials.gov/study/NCT04484675

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are scheduled to have mitral valve (heart valve) surgery using a heart-lung bypass machine
Before your surgery, a special ultrasound test of your heart showed that the blood pressure in your lung arteries is significantly high (at or above a certain level measured during that test)

Who may not be able to join:

Your surgery is planned without using a heart-lung bypass machine
You are currently in an unstable condition before surgery, meaning you already need medications or a medical device to keep your blood pressure and circulation stable
You have severely reduced heart pumping function (your heart is pumping less than 30% of its normal capacity)
You have a heart condition that was present from birth (congenital heart disease)
You have a medical reason why a special ultrasound probe placed in the throat and esophagus (food pipe) cannot be used during surgery
Your surgery is an emergency or a repeat operation on the same area
You have serious kidney or liver disease
You have a blood clotting disorder or a history of blood clots being treated with blood-thinning medications

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Zagazig University

Registry

ClinicalTrials.gov

Start date

20 May 2023

Est. completion

10 May 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

mean arterial pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov